Press release
Acute Myeloid Leukemia Market Size and Share to grow by 2032, estimates DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli Lilly
Acute Myeloid Leukemia Market
Request for sample request @ https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Acute Myeloid Leukemia Market Report
• As per DelveInsight's analysis, the acute myeloid leukemia market is anticipated to grow at a significant CAGR by 2032.
• As per the DelveInsight estimates, in 2022, the total incident cases of AML were ~42K in the 7MM, which might reach ~48K cases by 2032. In the 7MM, the highest number of incident cases of AML was observed in the US.
• Leading acute myeloid leukemia companies such as CicloMed LLC, Jazz Pharmaceuticals, Minneamrita Therapeutics LLC, Syndax Pharmaceuticals, Astex Pharmaceuticals, Inc., Karyopharm Therapeutics Inc, Sanofi, Polaris Group, Bio-Path Holdings, Inc., Chordia Therapeutics, Inc., Theradex, BioTheryX, Inc., Precigen, Inc, Eli Lilly and Company, Bayer, Takeda, Meryx, Inc., 2seventy bio, JW Pharmaceutical, Telios Pharma, Inc., Kartos Therapeutics, Inc., Celyad Oncology SA, Merck Sharp & Dohme LLC, Celgene, AbbVie, Genentech, Wugen, Inc., Arcellx, Inc, NextCure, Inc., Bellicum Pharmaceuticals, ImmunoGen, Inc., Astellas Pharma Inc, Aptose Biosciences Inc, Ascentage Pharma Group Inc., BioSight Ltd., GlycoMimetics Incorporated, Gilead Sciences, Chimerix, Daiichi Sankyo, Ryvu Therapeutics SA, Syros Pharmaceuticals, PrECOG, LLC, Cleave Therapeutics, Inc., Kronos Bio, Cullinan Oncology, LLC, Actinium Pharmaceuticals, Amgen, In8bio Inc, Sellas Life Sciences Group, Kura Oncology, Inc., Arog Pharmaceuticals, Inc., Novo Nordisk A/S, Marker Therapeutics, Inc., Shattuck Labs, Inc., Oncoceutics, Inc., and others are developing novel acute myeloid leukemia drugs that can be available in the acute myeloid leukemia market in the coming years.
• Some of the key therapies for acute myeloid leukemia treatment include Fosciclopirox + Cytarabine, CPX-351, Minnelide, SNDX-5613, ASTX727, KPT-9274, SAR445419, ADI-PEG 20, BP1002, CTX-712, BTX-A51, PRGN-3006 T Cells, LY3214996, Regorafenib, GDX012, MRX-2843, SC-DARIC33, CWP232291, TL-895, KRT-232, CYAD-02, MK-0482, and others.
Discover which therapies are expected to grab the major acute myeloid leukemia market share @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Myeloid Leukemia Overview
Acute Myeloid Leukemia (AML) is a type of aggressive cancer that affects the bone marrow and blood. It primarily affects myeloid cells, which are responsible for producing red blood cells, platelets, and certain white blood cells. AML is characterized by the rapid proliferation of immature and abnormal myeloid cells, interfering with the production of healthy blood cells. The exact causes of AML are not always clear, but certain risk factors have been identified.
The symptoms of AML often appear suddenly and can be quite severe. Common symptoms include unexplained fatigue, recurrent infections, easy bruising or bleeding, frequent nosebleeds, shortness of breath, and pale skin. AML can also lead to an enlarged spleen or liver, leading to discomfort in the abdomen. Diagnosing AML typically involves a series of tests, starting with a complete blood count to check for abnormal blood cell counts. Further tests, such as bone marrow aspiration and biopsy, are conducted to examine the bone marrow for abnormal cells and confirm the AML diagnosis.
Request for sample report @ https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Myeloid Leukemia Epidemiology Segmentation
The acute myeloid leukemia epidemiology section provides insights into the historical and current acute myeloid leukemia patient pool and forecasted trends for the seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The acute myeloid leukemia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Acute Myeloid Leukemia Incident Cases
• Acute Myeloid Leukemia Gender-specific Cases
• Acute Myeloid Leukemia Age-specific Cases
• Acute Myeloid Leukemia Mutation-specific Cases
• Treated Cases of Acute Myeloid Leukemia by Line of Therapies
Download the report to understand which factors are driving acute myeloid leukemia epidemiology trends @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Myeloid Leukemia Treatment Market
The treatment for AML typically involves a combination of therapies, tailored to each patient's specific condition and health status. The primary goal of AML treatment is to achieve remission, where no cancer cells are detectable in the bone marrow. The main acute myeloid leukemia treatment approaches include chemotherapy, targeted therapy, and stem cell transplantation. Chemotherapy utilizes powerful drugs to destroy cancer cells, but it can also damage healthy cells, leading to side effects. Targeted therapy, on the other hand, aims to attack specific molecules or proteins involved in the growth of leukemia cells, reducing damage to normal cells. In some cases, stem cell transplantation may be recommended, particularly for patients with high-risk or relapsed AML. This procedure involves replacing damaged bone marrow with healthy stem cells from a compatible donor, either from a family member or an unrelated donor.
Advancements in research and personalized medicine have led to the development of novel treatments and therapies for AML. Clinical trials play a crucial role in evaluating new approaches and improving outcomes for patients. Multidisciplinary teams, including hematologists, oncologists, and other specialists, work closely together to provide comprehensive care, manage side effects, and support patients throughout their AML treatment journey. Early diagnosis and timely intervention remain essential factors in achieving successful outcomes for individuals facing this challenging disease.
To know more about acute myeloid leukemia treatment, visit @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Acute Myeloid Leukemia Therapies and Companies
• Fosciclopirox + Cytarabine: CicloMed LLC
• CPX-351: Jazz Pharmaceuticals
• Minnelide: Minneamrita Therapeutics LLC
• SNDX-5613: Syndax Pharmaceuticals
• ASTX727: Astex Pharmaceuticals, Inc.
• KPT-9274: Karyopharm Therapeutics Inc
• SAR445419: Sanofi
• ADI-PEG 20: Polaris Group
• BP1002: Bio-Path Holdings, Inc.
• CTX-712: Chordia Therapeutics, Inc./Theradex
• BTX-A51: BioTheryX, Inc.
• PRGN-3006 T Cells: Precigen, Inc
• LY3214996: Eli Lilly and Company
• Regorafenib: Bayer
• GDX012: Takeda
• MRX-2843: Meryx, Inc.
• SC-DARIC33: 2seventy bio
• CWP232291: JW Pharmaceutical
• TL-895: Telios Pharma, Inc.
• KRT-232: Kartos Therapeutics, Inc.
• CYAD-02: Celyad Oncology SA
• MK-0482: Merck Sharp & Dohme LLC
Learn more about the FDA-approved drugs for acute myeloid leukemia @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Myeloid Leukemia Market Dynamics
Acute myeloid leukemia was a rapidly evolving segment within the oncology market, and its dynamics were shaped by various factors. One key driver of the AML market was the rising global incidence of the disease, prompting increased demand for effective treatments. Pharmaceutical companies were heavily invested in research and development, focusing on novel therapies and targeted agents. The emergence of precision medicine and personalized treatment approaches allowed for more tailored and effective treatment options, leading to a shift from traditional chemotherapy to more innovative and potentially curative therapies.
In addition, the regulatory landscape played a crucial role in shaping the AML market dynamics. Expedited approval pathways, such as Breakthrough Therapy Designation and Fast Track designation, facilitated the accelerated introduction of promising drugs to the acute myeloid leukemia market, benefiting patients by providing quicker access to new treatments.
However, challenges persisted in the AML market, particularly related to the high cost of innovative therapies and the limited accessibility to these treatments in certain regions. Efforts were being made to address these issues, such as healthcare reforms and collaborations between governments, healthcare providers, and pharmaceutical companies. Furthermore, ongoing research and clinical trials continued to shed light on the underlying biology of AML, leading to a better understanding of disease mechanisms and potential therapeutic targets. This knowledge expansion fueled the development of more precise and effective treatments, promising better outcomes for patients in the future.
Acute Myeloid Leukemia Report Metrics
• Study Period: 2019-2032
• Acute Myeloid Leukemia Report Coverage: 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]
• Key Acute Myeloid Leukemia Companies: CicloMed LLC, Jazz Pharmaceuticals, Minneamrita Therapeutics LLC, Syndax Pharmaceuticals, Astex Pharmaceuticals, Inc., Karyopharm Therapeutics Inc, Sanofi, Polaris Group, Bio-Path Holdings, Inc., Chordia Therapeutics, Inc., Theradex, BioTheryX, Inc., Precigen, Inc, Eli Lilly and Company, Bayer, Takeda, Meryx, Inc., 2seventy bio, JW Pharmaceutical, Telios Pharma, Inc., Kartos Therapeutics, Inc., Celyad Oncology SA, Merck Sharp & Dohme LLC, Celgene, AbbVie, Genentech, Wugen, Inc., Arcellx, Inc, NextCure, Inc., Bellicum Pharmaceuticals, ImmunoGen, Inc., Astellas Pharma Inc, Aptose Biosciences Inc, Ascentage Pharma Group Inc., BioSight Ltd., GlycoMimetics Incorporated, Gilead Sciences, Chimerix, Daiichi Sankyo, Ryvu Therapeutics SA, Syros Pharmaceuticals, PrECOG, LLC, Cleave Therapeutics, Inc., Kronos Bio, Cullinan Oncology, LLC, Actinium Pharmaceuticals, Amgen, In8bio Inc, Sellas Life Sciences Group, Kura Oncology, Inc., Arog Pharmaceuticals, Inc., Novo Nordisk A/S, Marker Therapeutics, Inc., Shattuck Labs, Inc., Oncoceutics, Inc., and others
• Key Acute Myeloid Leukemia Therapies : Fosciclopirox + Cytarabine, CPX-351, Minnelide, SNDX-5613, ASTX727, KPT-9274, SAR445419, ADI-PEG 20, BP1002, CTX-712, BTX-A51, PRGN-3006 T Cells, LY3214996, Regorafenib, GDX012, MRX-2843, SC-DARIC33, CWP232291, TL-895, KRT-232, CYAD-02, MK-0482, and others
Scope of the Acute Myeloid Leukemia Market Report
• Therapeutic Assessment: Acute Myeloid Leukemia current marketed and emerging therapies
• Acute Myeloid Leukemia Market Dynamics: Attribute Analysis of Emerging Acute Myeloid Leukemia Drugs
• Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
• Unmet Needs, KOL's views, Analyst's views, Acute Myeloid Leukemia Market Access and Reimbursement
Discover more about acute myeloid leukemia drugs in development @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Acute Myeloid Leukemia Market Key Insights
2. Acute Myeloid Leukemia Market Report Introduction
3. Acute Myeloid Leukemia Market Overview at a Glance
4. Acute Myeloid Leukemia Market Executive Summary
5. Disease Background and Overview
6. Acute Myeloid Leukemia Treatment and Management
7. Acute Myeloid Leukemia Epidemiology and Patient Population
8. Patient Journey
9. Acute Myeloid Leukemia Marketed Drugs
10. Acute Myeloid Leukemia Emerging Drugs
11. Seven Major Acute Myeloid Leukemia Market Analysis
12. Acute Myeloid Leukemia Market Outlook
13. Potential of Current and Emerging Therapies
14. KOL Views
15. Unmet Needs
16. SWOT Analysis
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
Trending Reports:
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Allergic Rhinoconjunctivitis Market: https://www.delveinsight.com/report-store/allergic-rhinoconjunctivitis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Heavy Metal Poisoning Markets: https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
• Nipah Virus Infection Market: https://www.delveinsight.com/report-store/nipah-virus-niv-infection-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Encephalitis Market: https://www.delveinsight.com/report-store/encephalitis-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Rett Syndrome Market: https://www.delveinsight.com/report-store/rett-syndrome-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Prosthetic Joint Infection Market: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Metastatic Bone Pain Market: https://www.delveinsight.com/report-store/metastatic-bone-pain-market
• Postsurgical Pain Market: https://www.delveinsight.com/report-store/postoperative-pain-market
• Acute Ocular Pain Market: https://www.delveinsight.com/report-store/acute-ocular-pain-market
• Bacteremia Market: https://www.delveinsight.com/report-store/bacteremia-market
• Cardiopulmonary Bypass Equipment Market: https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market
• Chronic Pain Associated With Painful Diabetic Neuropathy Market: https://www.delveinsight.com/report-store/chronic-pain-associated-with-painful-diabetic-neuropathy-market
• Generalized Pustular Psoriasis Market: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
• Parkinsons Disease Related Dementia Market: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Progressive Familial Intrahepatic Cholestasis Market: https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market
• Waiha Market: https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Egfr Non-small Cell Lung Cancer Market: https://www.delveinsight.com/report-store/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/central-retinal-venous-occulsion-market
• Age Related Vision Dysfunction Market: https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market
• Atopic Keratoconjunctivitis Akc Market: https://www.delveinsight.com/report-store/atopic-keratoconjunctivitis-market
• Hyperinsulinemic Hypoglycemia Market: https://www.delveinsight.com/report-store/congenital-hyperinsulinism-market
• Thyroid Eye Disease Market: https://www.delveinsight.com/report-store/thyroid-eye-disease-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Acrocallosal Syndrome Market: https://www.delveinsight.com/report-store/acrocallosal-syndrome-market
• Treatment Resistant Depression Market: https://www.delveinsight.com/report-store/treatment-resistant-depression-trd-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Absssi Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/food-allergy-market-insights
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Myeloid Leukemia Market Size and Share to grow by 2032, estimates DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli Lilly here
News-ID: 3187585 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Market:
Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report…
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion.
This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,…
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview:
The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,…
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects.
The International Technology Roadmap for Semiconductors (ITRS) has emphasized…
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by…
